Baby Beat
Financiado
Providing Clarity of Fetus Heartbeat Through Baby Beat Bracelet Measuring Fetal...
Providing Clarity of Fetus Heartbeat Through Baby Beat Bracelet Measuring Fetal Arterial Pulse Wave
Baby Beat represents our innovative response to the declining birthrate, increasing pregnancy risks and risks related to the generally higher age of pregnant women. It consists of a bracelet with integrated non-invasive technology...
Baby Beat represents our innovative response to the declining birthrate, increasing pregnancy risks and risks related to the generally higher age of pregnant women. It consists of a bracelet with integrated non-invasive technology that continuously measures the fetal heartbeat 24 hours, 7 days a week from around Week 20 of the pregnancy. This wearable device communicates with smart phones via Bluetooth and generates automatic alarms when the fetal heartbeat exceeds specific thresholds. The main innovations are that this method is non-invasive unlike all other devices available on the market and that it will be available at an attainable price of a few hundred euros. The overall objective of Phase II is to miniaturize the existing prototype, to test and demonstrate its usefulness on a larger group of pregnant women in clinical trials, and to obtain the necessary certifications for Baby Beat to become a medical device.
The market size for Baby Beat is promising when considering the number of pregnancies per year, following the trends of the prenatal retail market and considering the boom of non-invasive prenatal tests. There are 23 million pregnancies in the developed world itself. We will follow a two-tiered business model with direct sales through pharmacies and indirect sales through insurance companies, hospitals and clinics. This will allow us to boost our company growth and to create a significant amount of new jobs.
With our medical device and software, we foster the prevention of prenatal problems, and facilitate the provision of personalized care: high risk cases do not remain undiscovered, risk patients only proceed with visits if Baby Beat indicates a need, risk patients do not need to be hospitalized and different agents of the healthcare system will better coordinated.
ver más
Duración del proyecto: 21 meses
Fecha Inicio: 2015-07-07
Fecha Fin: 2017-04-30
Fecha Fin: 2017-04-30
Línea de financiación: concedida
El organismo H2020 notifico la concesión del proyecto el día 2017-04-30
Línea de financiación objetivo
El proyecto se financió a través de la siguiente ayuda:
Presupuesto
El presupuesto total del proyecto asciende a
1M€
Líder del proyecto
BCB INFORMATICA Y CONTROL
Prestacion de servicios de estudios y analisis de procesos para su tratamiento mecanico.. comprar y vender culaquier tipo de material electr...
Perfil tecnológico
TRL
4-5
150K
Perfil tecnológico
TRL
4-5
150K